##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 94 Download : 103

##plugins.themes.academic_pro.article.main##

Abstract

The high prevalence of urinary tract infections (UTIs) determines their high significance, not only medical, but also social. Every year, UTIs are the cause of outpatient visits and emergencyя medical care from the hospital[й [1]. Recently, it has been found that причиной UTI is caused уропатогенныеby uropathogenic E. Colistrains. ТакжеAn increase in the frequency of infections caused by gram-negative microorganisms was also noted, and therefore a further search for new drugs among cephalosporin antibiotics was aimed дляat creating drugs with increased activityagainst these microorganisms. New cephalosporin antibiotics are needed because of the huge increase in the number of drug-resistant bacteria

Keywords

antibacterial prevention antibacterial drugs urological operations

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Khakberdiyeva Gulzhakhon Erkinovna, Kasimova Shakhlo Shavkatovna, & Shirina Abrarovna Abdurazakova. (2024). Effective And Safe Use Of Cephalosporins In The Treatment Of Urinary Tract Infection. Texas Journal of Medical Science, 29, 21–24. https://doi.org/10.62480/tjms.2024.vol29.pp21-24
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Breast Cancer (Russian Medical Journal): https://www.rmj.ru/articles/obshchie-stati/Sovremennoe_znachenie_cefalosporinov_pri_lechenii_infekciy_v_stacionare/#ixzz8IRwGBaRq Under Creative Commons License: Attribution 2010–2019.
  2. Wagenlehner FME, Cloutier DJ, Komirenko AS, et al: Once-daily plazomicin for complicated urinary tract infections. N Engl J Med 380(8):729-740, 2019. doi: 10.1056/NEJMoa1801467
  3. Hoffmann H, Stindl S, Ludwig W, et al. Enterobacter hormaechei subsp.oharae subsp.nov., E. hormaechei subsp. hormaechei comb. nov., and E. hormaechei subsp. steigerwaltii subsp. nov., three new subspecies of clinical importance. J Clin Microbiol 2005; 43:3297–303. https://doi.org/10.1128/JCM.43.7. 3297–3303.2005
  4. Wilson BM, el Chakhtoura NG, Patel S, et al. Carbapenem-Resistant Enterobacter cloacae in patients from the US veterans health administration,
  5. –2015. Emerg Infect Dis 2017; 23:878–80. https://doi. org/10.3201/eid2305.162034 PMID: 28418318 6. Chen J, Tian S, Nian H, et al. Carbapenem-resistant Enterobacter cloacae complex in a tertiary hospital in northeast China, 2010–2019. BMC Infect Dis 2021; 21:611.
  6. Sidorenko S. V. Treatment of community-acquired urinary tract infections –
  7. the value of antibiotic resistance. // All-Russian scientificо- and practical conference "Modern principles of diagnosis, prevention and treatment of infectious and inflammatory- ванийdiseases of the kidneys, urinary tract and genitals" 8-9 February 2007. Abstracts of reports, pp. 124-127.
  8. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49(2):53-70
  9. Amir J., Harel L., Eidlitz–Markus T., Varsano I. Comparative evaluation of cefixime versus amoxicillinclavulanate following ceftriaxone therapy of pneumonia // Clin Pediatr (Phila). 1996. Vol. 35 (12). pp.629-633.
  10. Hodson E.M., Willis N.S., Craig J.C. Antibiotics for acute pyelonephritis in children // Cochrane Database Syst Rev. 2007 (4). CD003772.
  11. Ashkenazi S., Amir J., Waisman Y., Rachmel A., Garty B.Z., Samra Z., Varsano .I, Nitzan M. A randomized, double–blind study comparing cefixime and trimethoprim–sulfamethoxazole in the treatment of childhood shigellosis // J Pediatr. 1993. Vol. 123 (5). Р. 817–821.
  12. The original article is published on the website of Breast Cancer (Russian Medical Journal): https://www.rmj.ru/articles/klinicheskaya farmakologiya/Cefiksim terapii bakterialynyh infekciy voprosy effektivnosti
  13. Under Creative Commons License: Attribution The original article is published on the website of RMJ (Russian Medical Journal): https://www.rmj.ru/articles/klinicheskaya_farmakologiya/Cefiksim_v_terapii_bakterialynyh_infekciy_voprosy_effektivnosti_i_bezopasnosti/#ixzz8J1fZ5ROU
  14. Under Creative Commons License: Attribution
  15. The original article is published on the website of Breast Cancer (Russian Medical Journal): https://www.rmj.ru/articles/klinicheskaya_farmakologiya/Cefiksim_v_terapii_bakterialynyh_infekciy_voprosy_effektivnosti_i_bezopasnosti/#ixzz8J1fNfdNs